NGL
Bullish signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Supports a bullish reading. Current ratio 1.05 · operating margin 12%
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Supports a bullish reading. Interesting trend — weekly bias up
ACHAT TOTAL: 26626 titres (~432002 USD)
- Insiders
- RAYMOND JOHN T
- Total bought
-
$432,002
Avg buy (VWAP, 90d window) $16.92 vs last close $15.10 (-10.7%)
- Total sold
-
—
Avg sell (VWAP, 90d window) $17.00 vs last close $15.10 (-11.2%)
- Last activity
- 2026-08-24
- Liquidity
- Thin $3,018,260/day · 20d vol
- Last synced
-
2026-09-25 21:10:43
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-27 | COLLINGSWORTH JAMES M | Buy | 2,289 | $17.00 | $38,913 | Form 4 |
| 2026-08-26 | COLLINGSWORTH JAMES M | Buy | 200 | $16.96 | $3,392 | Form 4 |
| 2026-08-25 | COLLINGSWORTH JAMES M | Buy | 10,808 | $16.82 | $181,834 | Form 4 |
| 2026-08-25 | KRIMBILL H MICHAEL | Sell | 300,000 | $17.00 | $5,100,000 | Form 4 |
| 2026-08-25 | RAYMOND JOHN T | Buy | 300,000 | $16.98 | $5,094,000 | Form 4 |
| 2026-08-24 | RAYMOND JOHN T | Buy | 25,500 | $16.22 | $413,704 | Form 4 |
| 2026-08-21 | RAYMOND JOHN T | Buy | 1,126 | $16.25 | $18,298 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bullish signalScored 2026-09-20
NGL presents a compelling near-term earnings catalyst — a Q1 FY2027 beat, raised EBITDA guidance to $725M+, and meaningful insider buying — but these positives are severely undermined by deeply distressed fundamentals…
The first sentence of the analysis written for NGL on 2026-09-20 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 23.7% | 20.4% | 16.9% | 12.6% | 6.5% | |
| Ebit Margin | 2.4% | 9.4% | 2.4% | 4.7% | 0.9% | |
| Ebitda Margin | 10.7% | 17.2% | 9.2% | 9.8% | 4.8% | |
| Operating Profit Margin | 12.2% | 9.5% | 3.9% | 4.3% | 1.0% | |
| Pretax Profit Margin | -5.7% | 1.7% | -3.8% | 0.2% | -2.3% | |
| Continuous Operations Profit Margin | -5.7% | 1.9% | -3.8% | 0.2% | -2.3% | |
| Net Profit Margin | -5.7% | 1.1% | -3.5% | 0.9% | -2.3% | |
| Bottom Line Profit Margin | -14.1% | -2.3% | -6.8% | -1.3% | -3.6% | |
| Current Ratio | 1.047 | 1.301 | 1.208 | 1.164 | 1.211 | |
| Quick Ratio | 0.956 | 1.207 | 1.099 | 1.036 | 1.014 | |
| Solvency Ratio | 0.019 | 0.078 | 0.034 | 0.083 | 0.025 | |
| Cash Ratio | 0.012 | 0.008 | 0.040 | 0.005 | 0.003 | |
| Price To Earnings Ratio | -3.533 | -7.567 | -2.710 | -5.179 | -1.000 | |
| Price To Earnings Growth Ratio | -0.007 | 0.105 | -0.010 | 0.069 | 0.016 | |
| Forward Price To Earnings Growth Ratio | -0.007 | 0.105 | -0.010 | 0.069 | 0.016 | |
| Price To Earnings Diluted Ratio | -3.533 | -7.567 | -2.710 | -5.179 | -1.000 | |
| Price To Earnings Diluted Growth Ratio | -0.007 | 0.105 | -0.010 | 0.069 | 0.016 | |
| Price To Book Ratio | 60.453 | 0.886 | 0.741 | 0.280 | 0.222 | |
| Price To Sales Ratio | 0.496 | 0.173 | 0.185 | 0.067 | 0.036 | |
| Price To Free Cash Flow Ratio | 10.825 | 11.605 | 14.840 | 1.277 | 4.540 | |
| Price To Operating Cash Flow Ratio | 4.280 | 2.015 | 2.577 | 0.853 | 1.400 | |
| Debt To Assets Ratio | 0.804 | 0.669 | 0.591 | 0.541 | 0.571 | |
| Debt To Equity Ratio | 129.595 | 4.557 | 2.869 | 2.178 | 2.666 | |
| Debt To Capital Ratio | 0.992 | 0.820 | 0.742 | 0.685 | 0.727 | |
| Long Term Debt To Capital Ratio | 0.992 | 0.814 | 0.733 | 0.678 | 0.720 | |
| Financial Leverage Ratio | 161.174 | 6.812 | 4.856 | 4.028 | 4.667 | |
| Working Capital Turnover Ratio | 24.534 | 16.282 | 21.541 | 25.159 | 43.411 | |
| Operating Cash Flow Ratio | 0.495 | 0.402 | 0.304 | 0.401 | 0.161 | |
| Operating Cash Flow Sales Ratio | 0.116 | 0.086 | 0.072 | 0.078 | 0.026 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.395 | 0.174 | 0.174 | 0.668 | 0.308 | |
| Debt Service Coverage Ratio | 1.127 | 2.077 | 1.302 | 1.905 | 1.466 | |
| Interest Coverage Ratio | 1.513 | 1.176 | 0.636 | 0.943 | 0.326 | |
| Short Term Operating Cash Flow Coverage Ratio | 8.147 | 33.783 | 8.175 | 13.030 | 86.563 | |
| Operating Cash Flow Coverage Ratio | 0.109 | 0.096 | 0.100 | 0.151 | 0.059 | |
| Capital Expenditure Coverage Ratio | 1.654 | 1.210 | 1.210 | 3.013 | 1.446 | |
| Dividend Paid And Capex Coverage Ratio | 1.093 | 0.540 | 0.540 | 3.013 | 1.446 | |
| Dividend Payout Ratio | -0.630 | 7.755 | -2.124 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 14.591 | 6.181 | 9.708 | 5.958 | 9.930 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 23.7% | ▲3.3% | ▲7.6% |
| Ebit Margin | 2.4% | ▼-7.1% | ▼-1.6% |
| Ebitda Margin | 10.7% | ▼-6.5% | ▲0.4% |
| Operating Profit Margin | 12.2% | ▲2.7% | ▲6.0% |
| Pretax Profit Margin | -5.7% | ▼-7.4% | ▼-3.7% |
| Continuous Operations Profit Margin | -5.7% | ▼-7.5% | ▼-3.7% |
| Net Profit Margin | -5.7% | ▼-6.8% | ▼-3.8% |
| Bottom Line Profit Margin | -14.1% | ▼-11.8% | ▼-8.5% |
| Current Ratio | 1.047 | ▼-0.255 | ▼-0.140 |
| Quick Ratio | 0.956 | ▼-0.251 | ▼-0.107 |
| Solvency Ratio | 0.019 | ▼-0.059 | ▼-0.029 |
| Cash Ratio | 0.011 | ▲0.004 | ▼-0.002 |
| Price To Earnings Ratio | -3.533 | ▲4.034 | ▲0.465 |
| Price To Earnings Growth Ratio | -0.007 | ▼-0.113 | ▼-0.042 |
| Forward Price To Earnings Growth Ratio | -0.007 | ▼-0.113 | ▼-0.042 |
| Price To Earnings Diluted Ratio | -3.533 | ▲4.034 | ▲0.465 |
| Price To Earnings Diluted Growth Ratio | -0.007 | ▼-0.113 | ▼-0.042 |
| Price To Book Ratio | 60.453 | ▲59.568 | ▲47.937 |
| Price To Sales Ratio | 0.496 | ▲0.324 | ▲0.305 |
| Price To Free Cash Flow Ratio | 10.825 | ▼-0.779 | ▲2.208 |
| Price To Operating Cash Flow Ratio | 4.280 | ▲2.265 | ▲2.055 |
| Debt To Assets Ratio | 0.804 | ▲0.135 | ▲0.169 |
| Debt To Equity Ratio | 129.595 | ▲125.037 | ▲101.222 |
| Debt To Capital Ratio | 0.992 | ▲0.172 | ▲0.199 |
| Long Term Debt To Capital Ratio | 0.992 | ▲0.178 | ▲0.204 |
| Financial Leverage Ratio | 161.174 | ▲154.363 | ▲124.867 |
| Working Capital Turnover Ratio | 24.534 | ▲8.251 | ▼-1.652 |
| Operating Cash Flow Ratio | 0.495 | ▲0.092 | ▲0.142 |
| Operating Cash Flow Sales Ratio | 0.116 | ▲0.030 | ▲0.040 |
| Free Cash Flow Operating Cash Flow Ratio | 0.395 | ▲0.222 | ▲0.051 |
| Debt Service Coverage Ratio | 1.127 | ▼-0.949 | ▼-0.448 |
| Interest Coverage Ratio | 1.512 | ▲0.337 | ▲0.594 |
| Short Term Operating Cash Flow Coverage Ratio | 8.148 | ▼-25.636 | ▼-21.792 |
| Operating Cash Flow Coverage Ratio | 0.109 | ▲0.013 | ▲0.006 |
| Capital Expenditure Coverage Ratio | 1.654 | ▲0.444 | ▼-0.053 |
| Dividend Paid And Capex Coverage Ratio | 1.093 | ▲0.553 | ▼-0.233 |
| Dividend Payout Ratio | -0.630 | ▼-8.385 | ▼-1.630 |
| Enterprise Value Multiple | 14.591 | ▲8.411 | ▲5.318 |
Key metrics
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Market cap | $1.57B | $599.3M | $766.4M | $379.9M | $288.2M | |
| Enterprise value | $4.92B | $3.68B | $3.69B | $3.32B | $3.75B | |
| EV / Sales | 1.56x | 1.06x | 0.89x | 0.58x | 0.47x | |
| EV / Op. cash flow | 13.43x | 12.36x | 12.41x | 7.47x | 18.22x | |
| EV / Free cash flow | 33.97x | 71.20x | 71.51x | 11.18x | 59.09x | |
| EV / EBITDA | 14.59x | 6.18x | 9.71x | 5.96x | 9.93x | |
| Net debt / EBITDA | 9.94x | 5.17x | 7.69x | 5.28x | 9.17x | |
| Current ratio | 1.05x | 1.30x | 1.21x | 1.16x | 1.21x | |
| Income quality | -2.63x | 6.89x | 6.89x | 8.48x | -1.12x | |
| Graham number | — | $6 | — | $10 | — | |
| Graham net-net | -$29 | -$26 | -$26 | -$25 | -$29 | |
| Tax burden | 100.8% | 65.5% | 92.0% | 555.3% | 100.9% | |
| Interest burden | -237.1% | 18.3% | -158.9% | 3.5% | -255.9% | |
| Working capital | $34.5M | $222.8M | $203.3M | $182.3M | $269.1M | |
| Invested capital | $3.40B | $3.83B | $3.93B | $4.25B | $4.71B | |
| Return on assets | -4.3% | 0.9% | -2.9% | 0.9% | -3.0% | |
| Operating ROA | 8.8% | 6.8% | 3.1% | 4.2% | 1.4% | |
| Return on tangible assets | -6.0% | 1.2% | -4.1% | 1.4% | -4.4% | |
| Return on equity | -695.5% | 5.8% | -13.9% | 3.8% | -14.2% | |
| Return on invested capital | 11.0% | 8.4% | 4.0% | 5.4% | 1.7% | |
| Return on capital employed | 11.2% | 8.5% | 4.0% | 5.6% | 1.7% | |
| Earnings yield | -11.5% | 6.6% | -18.8% | 13.5% | -64.1% | |
| Free cash flow yield | 9.2% | 8.6% | 6.7% | 78.3% | 22.0% | |
| Capex / Op. cash flow | 60.5% | 82.6% | 82.6% | 33.2% | 69.2% | |
| Capex / Depreciation | 82.3% | 92.0% | 92.0% | 50.8% | 46.5% | |
| Capex / Sales | 7.0% | 7.1% | 5.9% | 2.6% | 1.8% | |
| SG&A / Sales | 11.5% | 1.6% | 2.9% | 1.3% | 0.8% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.4% | 0.0% | 0.0% | 0.0% | -0.0% | |
| Intangibles / Total assets | 27.7% | 31.1% | 30.5% | 32.2% | 30.7% | |
| Days sales outstanding | 77d | 61d | 63d | 67d | 52d | |
| Days payables outstanding | 75d | 61d | 68d | 68d | 53d | |
| Operating cycle | 88d | 71d | 75d | 78d | 64d | |
| Cash conversion cycle | 13d | 10d | 7d | 10d | 11d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+161.3%EV / Sales ▲+46.9%EV / EBITDA ▲+136.1%EV / Op. cash flow ▲+1.068Earnings yield ▼-0.181
Profitability
Return on equity ▼-7.013Return on assets ▼-0.052Return on invested capital ▲+0.026Return on capital employed ▲+0.027Operating ROA ▲+0.019Income quality ▼-9.521Tax burden ▲+0.353
Efficiency
Days sales outstanding ▲+16.067Days payables outstanding ▲+13.960Operating cycle ▲+17.032Cash conversion cycle ▲+3.071Capex / Sales ▼-0.001R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.255Net debt / EBITDA ▲+4.768Working capital ▼-188355000.000Invested capital ▼-436985000.000Intangibles / Total assets ▼-0.034
Change over 5 years
Valuation
Market cap ▲+443.3%EV / Sales ▲+229.9%EV / EBITDA ▲+46.9%EV / Op. cash flow ▼-4.793Earnings yield ▲+0.526
Profitability
Return on equity ▼-6.813Return on assets ▼-0.013Return on invested capital ▲+0.093Return on capital employed ▲+0.095Operating ROA ▲+0.074Income quality ▼-1.512Tax burden ▼-0.001
Efficiency
Days sales outstanding ▲+25.505Days payables outstanding ▲+21.718Operating cycle ▲+23.363Cash conversion cycle ▲+1.645Capex / Sales ▲+0.052R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.164Net debt / EBITDA ▲+0.774Working capital ▼-234669000.000Invested capital ▼-1312140000.000Intangibles / Total assets ▼-0.030
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2025-02-28 | Mark Dr Green | Sale (Full) | $15,001 - $50,000 |
| 2025-02-03 | Mark Dr Green | Sale | $250,001 - $500,000 |
| 2025-01-30 | Mark Dr Green | Sale | $500,001 - $1,000,000 |
| 2025-01-28 | Mark Dr Green | Sale | $50,001 - $100,000 |
| 2025-01-02 | Mark Dr Green | Sale (Full) | $15,001 - $50,000 |
| 2024-12-03 | Mark Dr Green | Sale (Full) | $15,001 - $50,000 |
| 2024-10-24 | Mark Dr Green | Sale (Full) | $50,001 - $100,000 |
| 2024-10-16 | Mark Dr Green | Sale (Full) | $50,001 - $100,000 |
| 2024-09-30 | Mark Dr Green | Sale (Full) | $100,001 - $250,000 |
| 2024-09-17 | Mark Dr Green | Sale (Full) | $1,001 - $15,000 |
| 2024-08-28 | Mark Dr Green | Sale (Full) | $50,001 - $100,000 |
| 2024-08-05 | Mark Dr Green | Sale (Full) | $50,001 - $100,000 |
| 2024-07-24 | Mark Dr Green | Sale (Full) | $15,001 - $50,000 |
| 2024-07-01 | Mark Dr Green | Sale (Full) | $50,001 - $100,000 |
| 2024-06-03 | Mark Dr Green | Sale (Full) | $100,001 - $250,000 |
| 2024-05-10 | Mark Dr Green | Sale (Full) | $15,001 - $50,000 |
| 2024-05-07 | Mark Dr Green | Sale (Full) | $250,001 - $500,000 |
| 2024-04-25 | Mark Dr Green | Sale (Full) | $100,001 - $250,000 |
| 2024-04-01 | Mark Dr Green | Sale (Full) | $100,001 - $250,000 |
| 2024-03-11 | Mark Dr Green | Sale (Full) | $15,001 - $50,000 |
| 2024-02-26 | Mark Dr Green | Sale (Full) | $50,001 - $100,000 |
| 2024-01-29 | Mark Dr Green | Sale (Full) | $100,001 - $250,000 |
| 2024-01-11 | Mark Dr Green | Sale (Full) | $100,001 - $250,000 |
| 2023-08-04 | Mark Dr Green | Purchase | $250,001 - $500,000 |
| 2023-06-08 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2023-06-02 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2023-03-24 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2023-01-03 | Mark Dr Green | Sale (Full) | $1,001 - $15,000 |
| 2022-08-29 | Mark Dr Green | Sale (Full) | $1,001 - $15,000 |
| 2022-06-02 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2022-01-12 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2022-01-06 | Mark Dr Green | Purchase | $50,001 - $100,000 |
| 2021-12-21 | Mark Dr Green | Sale (Full) | $15,001 - $50,000 |
| 2021-11-17 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2021-05-20 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2021-05-06 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2021-05-05 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2021-04-21 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2021-03-17 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2021-03-12 | Mark Dr Green | Purchase | $50,001 - $100,000 |
| 2021-03-04 | Mark Dr Green | Sale (Full) | $100,001 - $250,000 |
| 2021-02-24 | Mark Dr Green | Sale (Full) | $100,001 - $250,000 |
| 2021-02-18 | Mark Dr Green | Sale (Full) | $100,001 - $250,000 |
| 2021-01-19 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-12-01 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-11-24 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-11-18 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-11-17 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-11-13 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-11-10 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-11-09 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-10-16 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2020-10-15 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2020-10-05 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2020-10-05 | Mark Dr Green | Sale (Full) | $100,001 - $250,000 |
| 2020-09-11 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2020-08-12 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-08-11 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-08-04 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2020-07-08 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-07-07 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-07-02 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-06-11 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2020-06-10 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-06-10 | Mark Dr Green | Purchase | $50,001 - $100,000 |
| 2020-02-27 | Kevin Hern | Sale (Full) | $15,001 - $50,000 |
| 2020-02-14 | Kevin Hern | Purchase | $1,001 - $15,000 |
| 2019-05-15 | Kevin Hern | Purchase | $1,001 - $15,000 |
Recent news
- 2026-08-25 Strong Midstream 2Q26 Earnings Boost Full-Year Outlook Midstream MLPs and corporations generally posted strong second-quarter earnings, benefiting from record volume throughput, strong margins, and robust demand for natural gas and natural gas liquids (NGL) exports. Companies also demonstrated the defensive nature of their fee-based cash flows.
- 2026-08-21 NGL Energy Partners LP (NGL) is a Great Momentum Stock: Should You Buy? Does NGL Energy Partners LP (NGL) have what it takes to be a top stock pick for momentum investors? Let''s find out.
- 2026-08-11 Surging Earnings Estimates Signal Upside for NGL Energy Partners (NGL) Stock NGL Energy Partners LP (NGL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 2026-08-05 NGL Is Quickly Becoming A Key Player NGL Energy Partners delivered a strong Q1 EBITDA and volume beat, driven by 43% growth in the Water Solutions segment. Management raised full-year adjusted EBITDA guidance to $725-$735 million and signaled potential for further upward revisions. The LEX II Extension project is set to drive ~15% organic water volume growth by fiscal Q4, underpinned by new long-term contracts.
- 2026-08-05 Energy Transfer Is A Beat And Raise Machine Energy Transfer (ET) delivered another beat-and-raise quarter, with Q2 EBITDA of $5.07B and raised full-year guidance to $18.8–$19.1B. Operational momentum is robust: record NGL transportation, exports, and crude oil volumes, with distributable cash flow up to $2.59B. Growth initiatives span power generation, LNG exports, and NGL infrastructure, with major projects like the Hugh Brinson Pipeline and Mustang Draw I online.
- 2026-08-05 NGL Energy Partners Q1 Earnings Call Highlights NGL Energy Partners NYSE: NGL reported a strong start to fiscal 2027, led by record produced-water disposal volumes and higher earnings from its Water Solutions segment, while raising its full-year adjusted EBITDA outlook by $10 million.
- 2026-08-04 NGL Energy Partners LP Common Units (NGL) Q1 2027 Earnings Call Transcript NGL Energy Partners LP Common Units (NGL) Q1 2027 Earnings Call Transcript
- 2026-08-04 NGL Energy Partners LP Announces First Quarter Fiscal 2027 Financial Results TULSA, Okla.--(BUSINESS WIRE)--NGL Energy Partners LP Announces First Quarter Fiscal 2027 Financial Results.
- 2026-07-31 NGL Energy Partners LP Announces Availability of its 2025 Schedule K-3s TULSA, Okla.--(BUSINESS WIRE)--NGL Energy Partners LP Announces Availability of its 2025 Schedule K-3s.
- 2026-07-29 Boomers Are Buying 5 Quality High-Yield Stocks at Big Discounts Hand Over Fist While many Baby Boomers have enjoyed a long bull market over the past 35 years, there is a point when income becomes more critical than stock appreciation.